Houston, TX, United States of America

Richard T Lewis

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Renowned Inventor Richard T Lewis: Trailblazing Innovations in Healthcare

Introduction: Richard T Lewis, a visionary inventor based in Houston, TX, USA, is a pioneering force in the world of innovation with a profound impact on healthcare through his groundbreaking creations.

Latest Patents: With a notable patent titled "Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use", Lewis introduces a new class of compounds aimed at modulating beta-secretase enzyme activity to address disorders related to A-beta plaque formation, including Alzheimer's Disease and cognitive impairments.

Career Highlights: Lewis has displayed remarkable expertise and dedication while working at Amgen Inc., a leading pharmaceutical company. His journey as an inventor has been characterized by a relentless pursuit of excellence and a commitment to advancing medical science.

Collaborations: Throughout his career, Lewis has collaborated with esteemed colleagues such as Jennifer Rebecca Allen and Yuan Cheng. Together, they have embarked on innovative projects that have the potential to revolutionize the field of healthcare with their novel approaches and solutions.

Conclusion: Richard T Lewis stands as a true luminary in the realm of inventions, continuously pushing the boundaries of innovation to create transformative technologies that have the power to enhance and prolong lives. His invaluable contributions to the healthcare industry underscore his unwavering dedication to improving the quality of life for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…